Prenatal caffeine exposure: association with neurodevelopmental outcomes in 9- to 11-year-old children

Rui Zhang1, Peter Manza1, Nora D Volkow1,2

  • 1Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA.

Insights

Prenatal caffeine exposure, even at recommended doses, is linked to increased behavioral issues and altered brain structure in children. Further research is needed to determine if the "safe" caffeine limit during pregnancy requires adjustment.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Public Health

Background:

  • Caffeine is widely consumed, including during pregnancy.
  • The impact of prenatal caffeine exposure on child development remains unclear.

Purpose of the Study:

  • To investigate the association between prenatal caffeine exposure and child developmental outcomes.
  • To explore dose-dependent effects of caffeine exposure on behavior and brain structure.

Main Methods:

  • Utilized data from the Adolescent Brain and Cognitive Development Study (n=11,875 children aged 9-11).
  • Analyzed associations between prenatal caffeine exposure levels and various child outcomes.
  • Included birth outcomes, physical health, behavior, cognition, substance use, and brain structure.

Main Results:

  • Prenatal caffeine exposure, including recommended doses, correlated with increased externalizing behavior problems.
  • Higher caffeine intake was linked to greater BMI and soda consumption.
  • Observed brain structural changes included altered cortical thickness and sulcal depth.
  • Effect sizes for externalizing problems were comparable to those of prenatal alcohol and cannabis exposure.

Conclusions:

  • The "safe" caffeine dose during pregnancy warrants further investigation for clinical relevance and potential adjustment.
  • Prenatal caffeine use should be considered as a covariate in studies of prenatal drug exposure due to its high prevalence.
Abstract

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
458
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.2K
Information Processing Approach01:30

Information Processing Approach

The information-processing theory of cognitive development centers on fundamental mental processes, including attention, memory, and problem-solving skills. Researchers in this field examine how cognitive abilities, such as working memory, evolve and influence children's overall development. Studies indicate that children with stronger working memory tend to excel in reading comprehension, math, and problem-solving compared to peers with less efficient memory skills. Low working memory is...
235